Andrx To Market Alphapharm Paxil Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Andrx will market Alphapharm's generic paroxetine (GlaxoSmithKline's Paxil) "shortly" under an agreement announced May 12
You may also be interested in...
Revenues Up Despite Paroxetine Competition And Disappointing Ribavirin Launch, Par Says
Par's second quarter revenues jumped despite disappointing revenues from the company's ribavirin generic and lower sales for paroxetine
Revenues Up Despite Paroxetine Competition And Disappointing Ribavirin Launch, Par Says
Par's second quarter revenues jumped despite disappointing revenues from the company's ribavirin generic and lower sales for paroxetine
Paxil ANDAs From Alphapharm, Sandoz Receive Final Approval From FDA
TorPharm's exclusivity for paroxetine (GlaxoSmithKline's Paxil) comes to an end. FDA had tentatively approved both Alphapharm's and Sandoz' ANDAs.